Broadening Gene Therapy's Reach With Novel Capsids

LogicBio's Mariana Nacht, PhD, shares details of the company's novel capsid discovery platform and gene editing technology.

Gene Therapies for ALS, Friedreich’s Ataxia the Focus of New CRISPR, Capsida Partnership

The news comes after CRISPR’s favorable data readouts in its sickle cell and beta thalassemia studies.

Mesenchymal Stem Cells Hold Promise for Osteoarthritis and More Chronic Diseases

Cynata Therapeutics' Ross Macdonald, PhD, discusses the company's pipeline and clinical-phase trials.